These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 18790463)

  • 1. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.
    Rice DP; Fillit HM; Max W; Knopman DS; Lloyd JR; Duttagupta S
    Am J Manag Care; 2001 Aug; 7(8):809-18. PubMed ID: 11519239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of donepezil therapy on health costs in a Medicare managed care plan.
    Hill JW; Futterman R; Mastey V; Fillit H
    Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of comorbidity on costs for patients with Alzheimer disease.
    Kuo TC; Zhao Y; Weir S; Kramer MS; Ash AS
    Med Care; 2008 Aug; 46(8):839-46. PubMed ID: 18665064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
    Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
    Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacoeconomics of Alzheimer's disease.
    Fillit HM
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1139-44; discussion S1145-8. PubMed ID: 11142178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes.
    Nguyen HQ; Ackermann RT; Berke EM; Cheadle A; Williams B; Lin E; Maciejewski ML; LoGerfo JP
    Diabetes Care; 2007 Jan; 30(1):43-8. PubMed ID: 17192331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct costs of blindness experienced by patients enrolled in managed care.
    Frick KD; Walt JG; Chiang TH; Doyle JJ; Stern LS; Katz LM; Dolgitser M; Hendlish SK
    Ophthalmology; 2008 Jan; 115(1):11-7. PubMed ID: 17475331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
    Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of illness among commercially insured patients with Alzheimer's disease.
    Joyce AT; Zhao Y; Bowman L; Flynn JA; Carter CT; Ollendorf DA
    Alzheimers Dement; 2007 Jul; 3(3):204-10. PubMed ID: 19595939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Alzheimer's disease and association with negative health outcomes.
    Malone DC; McLaughlin TP; Wahl PM; Leibman C; Arrighi HM; Cziraky MJ; Mucha LM
    Am J Manag Care; 2009 Aug; 15(8):481-8. PubMed ID: 19670951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of atrial fibrillation in United States managed care organizations.
    Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
    Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
    Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J
    J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of costs of care for patients with Alzheimer's disease.
    Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
    Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.